%0 Journal Article %1 Pryde2004 %A Pryde, Peter G %A Janeczek, Susan %A Mittendorf, Robert %D 2004 %J Expert Opin Drug Saf %K Adrenergic beta-Agonists; Adult; Calcium Channel Blockers; Cerebral Hemorrhage; Palsy; Cyclooxygenase Inhibitors; Female; Fetal Diseases; Hormone Antagonists; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Oxytocin; Pre-Eclampsia; Pregnancy; Risk Assessment; Tocolysis; Tocolytic Agents %N 6 %P 639--654 %T Risk-benefit effects of tocolytic therapy. %V 3

@article{Pryde2004, added-at = {2014-07-19T21:06:52.000+0200}, author = {Pryde, Peter G and Janeczek, Susan and Mittendorf, Robert}, biburl = {https://www.bibsonomy.org/bibtex/2277cf67ec1cda1a1a6ada1edc459713a/ar0berts}, groups = {public}, interhash = {2fac4cd5fd934914a346814950adc997}, intrahash = {277cf67ec1cda1a1a6ada1edc459713a}, journal = {Expert Opin Drug Saf}, keywords = {Adrenergic beta-Agonists; Adult; Calcium Channel Blockers; Cerebral Hemorrhage; Palsy; Cyclooxygenase Inhibitors; Female; Fetal Diseases; Hormone Antagonists; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Oxytocin; Pre-Eclampsia; Pregnancy; Risk Assessment; Tocolysis; Tocolytic Agents}, month = Nov, number = 6, pages = {639--654}, pii = {EDS030612}, pmid = {15500422}, timestamp = {2014-07-19T21:06:52.000+0200}, title = {Risk-benefit effects of tocolytic therapy.}, username = {ar0berts}, volume = 3, year = 2004 }